1. Home
  2. CRDL vs HUHU Comparison

CRDL vs HUHU Comparison

Compare CRDL & HUHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDL
  • HUHU
  • Stock Information
  • Founded
  • CRDL 2017
  • HUHU 2015
  • Country
  • CRDL Canada
  • HUHU China
  • Employees
  • CRDL N/A
  • HUHU N/A
  • Industry
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • HUHU
  • Sector
  • CRDL Health Care
  • HUHU
  • Exchange
  • CRDL Nasdaq
  • HUHU NYSE
  • Market Cap
  • CRDL 102.0M
  • HUHU 91.5M
  • IPO Year
  • CRDL N/A
  • HUHU 2024
  • Fundamental
  • Price
  • CRDL $1.03
  • HUHU $4.49
  • Analyst Decision
  • CRDL Strong Buy
  • HUHU
  • Analyst Count
  • CRDL 3
  • HUHU 0
  • Target Price
  • CRDL $9.00
  • HUHU N/A
  • AVG Volume (30 Days)
  • CRDL 226.1K
  • HUHU 54.1K
  • Earning Date
  • CRDL 05-13-2025
  • HUHU 02-22-2025
  • Dividend Yield
  • CRDL N/A
  • HUHU N/A
  • EPS Growth
  • CRDL N/A
  • HUHU 13.14
  • EPS
  • CRDL N/A
  • HUHU 0.08
  • Revenue
  • CRDL N/A
  • HUHU $17,492,735.00
  • Revenue This Year
  • CRDL N/A
  • HUHU N/A
  • Revenue Next Year
  • CRDL N/A
  • HUHU N/A
  • P/E Ratio
  • CRDL N/A
  • HUHU $55.90
  • Revenue Growth
  • CRDL N/A
  • HUHU 33.03
  • 52 Week Low
  • CRDL $0.77
  • HUHU $2.95
  • 52 Week High
  • CRDL $3.12
  • HUHU $9.89
  • Technical
  • Relative Strength Index (RSI)
  • CRDL 50.17
  • HUHU N/A
  • Support Level
  • CRDL $0.92
  • HUHU N/A
  • Resistance Level
  • CRDL $1.08
  • HUHU N/A
  • Average True Range (ATR)
  • CRDL 0.11
  • HUHU 0.00
  • MACD
  • CRDL 0.02
  • HUHU 0.00
  • Stochastic Oscillator
  • CRDL 72.64
  • HUHU 0.00

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About HUHU HUHUTECH INTL GROUP INC

HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.

Share on Social Networks: